메뉴 건너뛰기




Volumn 61, Issue 1, 2009, Pages 46-51

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOSINE MONOPHOSPHATE DEAMINASE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INORGANIC PYROPHOSPHATASE; INOSINE TRIPHOSPHATE PYROPHOSPHATASE; METHOTREXATE; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE; SALAZOSULFAPYRIDINE; STEROID; UNCLASSIFIED DRUG;

EID: 58349116270     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24087     Document Type: Article
Times cited : (115)

References (19)
  • 1
    • 0035992960 scopus 로고    scopus 로고
    • Worldwide prevalence of juvenile arthritis: Why does it vary so much?
    • Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis: why does it vary so much? J Rheumatol 2002;29:1520-30.
    • (2002) J Rheumatol , vol.29 , pp. 1520-1530
    • Manners, P.J.1    Bower, C.2
  • 2
    • 10744230484 scopus 로고    scopus 로고
    • International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001
    • Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
    • (2004) J Rheumatol , vol.31 , pp. 390-392
    • Petty, R.E.1    Southwood, T.R.2    Manners, P.3    Baum, J.4    Glass, D.N.5    Goldenberg, J.6
  • 4
    • 0026609159 scopus 로고
    • Methotrexate in resistant juvenile rheumatoid arthritis: Results of the USA-USSR double-blind, placebo-controlled trial
    • for the Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group
    • Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, et al, for the Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. Methotrexate in resistant juvenile rheumatoid arthritis: results of the USA-USSR double-blind, placebo-controlled trial. N Engl J Med 1992;326:1043-9.
    • (1992) N Engl J Med , vol.326 , pp. 1043-1049
    • Giannini, E.H.1    Brewer, E.J.2    Kuzmina, N.3    Shaikov, A.4    Maximov, A.5    Vorontsov, I.6
  • 5
    • 0033875824 scopus 로고    scopus 로고
    • Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis
    • Woo P, Southwood TR, Prieur AM, Dore CJ, Grainger J, David J, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43:1849-57.
    • (2000) Arthritis Rheum , vol.43 , pp. 1849-1857
    • Woo, P.1    Southwood, T.R.2    Prieur, A.M.3    Dore, C.J.4    Grainger, J.5    David, J.6
  • 6
    • 0033503925 scopus 로고    scopus 로고
    • The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis
    • Ravelli A, Viola S, Migliavacca D, Ruperto N, Pistorio A, Martini A. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. J Pediatr 1999;135:316-20.
    • (1999) J Pediatr , vol.135 , pp. 316-320
    • Ravelli, A.1    Viola, S.2    Migliavacca, D.3    Ruperto, N.4    Pistorio, A.5    Martini, A.6
  • 7
    • 3142746016 scopus 로고    scopus 로고
    • A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate
    • for the Pediatric Rheumatology International Trials Organization
    • Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, et al, for the Pediatric Rheumatology International Trials Organization. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004;50:2191-201.
    • (2004) Arthritis Rheum , vol.50 , pp. 2191-2201
    • Ruperto, N.1    Murray, K.J.2    Gerloni, V.3    Wulffraat, N.4    de Oliveira, S.K.5    Falcini, F.6
  • 8
    • 39549121704 scopus 로고    scopus 로고
    • The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis
    • Bartoli M, Taro M, Magni-Manzoni S, Pistorio A, Traverso F, Viola S, et al. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Ann Rheum Dis 2008;67:370-4.
    • (2008) Ann Rheum Dis , vol.67 , pp. 370-374
    • Bartoli, M.1    Taro, M.2    Magni-Manzoni, S.3    Pistorio, A.4    Traverso, F.5    Viola, S.6
  • 9
    • 39449121672 scopus 로고    scopus 로고
    • Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis
    • Wessels JA, Huizinga TW, Guchelaar HJ. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2008;47:249-55.
    • (2008) Rheumatology (Oxford) , vol.47 , pp. 249-255
    • Wessels, J.A.1    Huizinga, T.W.2    Guchelaar, H.J.3
  • 10
    • 22944470530 scopus 로고    scopus 로고
    • Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis
    • Cronstein BN. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 2005;57:163-72.
    • (2005) Pharmacol Rev , vol.57 , pp. 163-172
    • Cronstein, B.N.1
  • 11
    • 24944562698 scopus 로고    scopus 로고
    • Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis
    • Schmeling H, Biber D, Heins S, Horneff G. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. J Rheumatol 2005;32:1832-6.
    • (2005) J Rheumatol , vol.32 , pp. 1832-1836
    • Schmeling, H.1    Biber, D.2    Heins, S.3    Horneff, G.4
  • 12
    • 33749370785 scopus 로고    scopus 로고
    • Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis
    • Wessels JA, Kooloos WM, De Jonge R, Vries-Bouwstra JK, Allaart CF, Linssen A, et al. Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2006;54:2830-9.
    • (2006) Arthritis Rheum , vol.54 , pp. 2830-2839
    • Wessels, J.A.1    Kooloos, W.M.2    De Jonge, R.3    Vries-Bouwstra, J.K.4    Allaart, C.F.5    Linssen, A.6
  • 13
    • 33646354882 scopus 로고    scopus 로고
    • Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes
    • Wessels JA, Vries-Bouwstra JK, Heijmans BT, Slagboom PE, Goekoop-Ruiterman YP, Allaart CF, et al. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum 2006;54:1087-95.
    • (2006) Arthritis Rheum , vol.54 , pp. 1087-1095
    • Wessels, J.A.1    Vries-Bouwstra, J.K.2    Heijmans, B.T.3    Slagboom, P.E.4    Goekoop-Ruiterman, Y.P.5    Allaart, C.F.6
  • 15
    • 6544295245 scopus 로고    scopus 로고
    • Responsiveness of outcome measures in juvenile chronic arthritis
    • and the Italian Pediatric Rheumatology Study Group
    • Ruperto N, Ravelli A, Falcini F, Lepore L, Buoncompagni A, Gerloni V, et al, and the Italian Pediatric Rheumatology Study Group. Responsiveness of outcome measures in juvenile chronic arthritis. Rheumatology (Oxford) 1999;38:176-80.
    • (1999) Rheumatology (Oxford) , vol.38 , pp. 176-180
    • Ruperto, N.1    Ravelli, A.2    Falcini, F.3    Lepore, L.4    Buoncompagni, A.5    Gerloni, V.6
  • 16
    • 15444352940 scopus 로고    scopus 로고
    • Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate
    • and the Italian Pediatric Rheumatology Study Group
    • Ruperto N, Ravelli A, Falcini F, Lepore L, De Sanctis R, Zulian F, et al, and the Italian Pediatric Rheumatology Study Group. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Ann Rheum Dis 1998;57:38-41.
    • (1998) Ann Rheum Dis , vol.57 , pp. 38-41
    • Ruperto, N.1    Ravelli, A.2    Falcini, F.3    Lepore, L.4    De Sanctis, R.5    Zulian, F.6
  • 17
    • 27844469668 scopus 로고    scopus 로고
    • Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids
    • Brik R, Gepstein V, Berkovitz D. Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids. Clin Rheumatol 2005;24:612-4.
    • (2005) Clin Rheumatol , vol.24 , pp. 612-614
    • Brik, R.1    Gepstein, V.2    Berkovitz, D.3
  • 18
    • 35948933049 scopus 로고    scopus 로고
    • Early rheumatoid arthritis: Is there a window of opportunity?
    • Cush JJ. Early rheumatoid arthritis: is there a window of opportunity? J Rheumatol Suppl 2007;80:1-7.
    • (2007) J Rheumatol Suppl , vol.80 , pp. 1-7
    • Cush, J.J.1
  • 19
    • 27744587808 scopus 로고    scopus 로고
    • The evidence for early intervention
    • Quinn MA, Cox S. The evidence for early intervention. Rheum Dis Clin North Am 2005;31:575-89.
    • (2005) Rheum Dis Clin North Am , vol.31 , pp. 575-589
    • Quinn, M.A.1    Cox, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.